Jiangsu Hengrui Medicine
600276.SS
#507
Rank
ยฃ30.61 B
Marketcap
ยฃ4.80
Share price
0.07%
Change (1 day)
-1.73%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07019. In 2022 the company made an earnings per share (EPS) of ยฃ0.06999 a decrease over its 2021 EPS that were of ยฃ0.08442.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075467.82%
2022ยฃ0.06999-17.1%
2021ยฃ0.08442-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0928725.58%
2018ยฃ0.0739527.55%
2017ยฃ0.0579821.64%
2016ยฃ0.0476713.57%
2015ยฃ0.0419739.86%
2014ยฃ0.0300121.33%
2013ยฃ0.0247317.7%
2012ยฃ0.0210125.56%
2011ยฃ0.0167426.22%
2010ยฃ0.0132610.3%
2009ยฃ0.0120257.92%
2008ยฃ0.00761211.06%
2007ยฃ0.00685485.81%
2006ยฃ0.00368987.94%
2005ยฃ0.00196333.97%
2004ยฃ0.00146529.78%
2003ยฃ0.00112919.78%
2002ยฃ0.0009423